Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market To Reach $452.5 Million By 2030

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market Growth & Trends

The Europe, MEA & CIS extracorporeal membrane oxygenation machine market size is expected to reach USD 452.5 million by 2030, registering a CAGR of 4.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. It is expected to exhibit a CAGR of 4.5% over the forecast period. Key factors contributing to the growth include increasing prevalence of respiratory failure and cardiopulmonary diseases and growing awareness regarding the benefits associated with the usage of ECMO machine. Moreover, rise in the number of patients suffering from Chronic Obstructive Pulmonary Disease (COPD) is anticipated to create demand for ECMO treatment.

High adoption of these devices can be attributed to introduction of innovative products and approval by regulatory bodies. In August 2017, the Ministry of Health (MoH) announced the launch of ECMO services in Asir region. This service was made available at three MoH’s healthcare centers located in Jeddah, Riyadh, and Dammam. Increased adoption of ECMO machines in hospitals and medical centers is anticipated to propel growth of Europe, MEA, and CIS extracorporeal membrane oxygenation machine market during the forecast period. According to Cincinnati Children’s Hospital Medical Center, survival rate without and with ECMO is about 20% and 60%, respectively. ECMO also helps in ventilation, oxygenation, and cardiac output. Such advantages provided have increased the adoption of these systems in hospitals, which in turn is projected to boost the Europe, MEA, and CIS ECMO machine market in the next few years.

 Request a free sample copy or view report summary: Europe, MEA, & CIS Extracorporeal Membrane Oxygenation Machine Market Report

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market Report Highlights

• The oxygenators dominated the market and accounted for the largest revenue share of 31.1% in 2023. They eliminate carbon dioxide and supply oxygenated blood to the patient’s body, which helps the heart and lungs recover.

• The veno-arterial led the market and accounted for the largest revenue share of 40.6% in 2023 attributed to its essential help for respiratory or cardiac failure patients, making it a required intervention in disorders with complications.

• Arterio-venous is expected to grow at a CAGR of 4.5% over the forecast period. The arterio-venous (AV) modality in extracorporeal membrane oxygenation (ECMO) machines plays an important role in the market due to its unique advantages such as its highly effective and better medical assessment linked with the technology.

• Respiratory applications dominated the market and accounted for the largest revenue share of 44.2% in 2023 driven by the rising aging population, treating respiratory disorders, such as respiratory failure, acute respiratory distress syndrome (ARDS), hypercapnia respiratory failure (HRF), pulmonary hypertension, respiratory distress syndrome, and severe pneumonia, influencing its wide range of applications.

• Growing number of intensive care units in Saudi Arabia, Turkey, Kuwait, and other countries is likely to boost market growth during the forecast period

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market Segmentation

Grand View Research has segmented the Europe, MEA & CIS extracorporeal membrane oxygenation machine market on the basis of on component, modality, application, and region:

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Component Outlook (Revenue, USD Million, 2018 - 2030)

• Pumps

• Oxygenators

• Controllers

• Cannula

• Accessories

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Veno-Arterial

• Veno-Venous

• Arterio-Venous

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Application Outlook (Revenue, USD Million, 2018 - 2030)

• Respiratory

• Cardiac

• ECPR

Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Regional Outlook (Revenue, USD Million, 2018 - 2030)

• Europe

  • Czech Republic

  • Russia

  • Estonia

  • Turkey

  • ROE

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Bahrain

  • Kuwait

  • Qatar

  • Oman

  • Israel

• Commonwealth and Independent States (CIS)

  • Azerbaijan

  • Armenia

  • Belarus

  • Uzbekistan

  • Kazakhstan

List of Key Players in the Europe, MEA & CIS Extracorporeal Membrane Oxygenation Machine Market

• Medtronic

• Microport Scientific Corporation.

• Terumo Cardiovascular Systems Corporation.

• Medos Austria

• Nipro Medical Corporation

• LivaNova PLC

• CYTOSORBENTS EUROPE GMBH

• EUROSETS

• Getinge